Resident Blog - Edith Ford
from The mTOR You Know Hosted by The mTOR You Know
PGY2 SOT Edith Ford joins us from Mayo Clinic in Phoenix, Arizona to discuss "A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection", which has recently received Breakthrough Therapy Designation for ABMR in kidney transplant recipients, as well as a quick discussion on antibody-mediated rejection and CD38 inhibitors.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The mTOR You Know?
This episode is 20 minutes long.
When was this The mTOR You Know episode published?
This episode was published on November 26, 2024.
Can I download this The mTOR You Know episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.